Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 5—May 2009
Research

CTX-M β-Lactamases in Escherichia coli from Community-acquired Urinary Tract Infections, Cambodia

Etienne RuppéComments to Author , Sopheak Hem, Sovannarith Lath, Valérie Gautier, Frédéric Ariey, Jean-Louis Sarthou, Didier Monchy, and Guillaume Arlet
Author affiliations: Institut Pasteur du Cambodge, Phnom Penh, Cambodia (E. Ruppé, S. Hem, S. Lath, F. Ariey, J.-L. Sarthou, D. Monchy); Université Pierre et Marie Curie-Paris Faculté de Médecine, Paris, France (V. Gautier, G. Arlet); Assistance Publique-Hôpitaux de Paris–Hôpital Tenon, Paris (V. Gautier, G. Arlet)

Main Article

Table 2

Resistance to antimicrobial agents among ESBL-positive and ESBL-negative Escherichia coli, Cambodia, 2004–2005*

Antimicrobial agent Resistance ratios, % (no. resistant strains)
 p value
ESBL+, n = 34 ESBL–, n = 59 Total, n = 93
Fluoroquinolones 94 (32) 53 (31) 68 (63) <0.001
Cotrimoxazole 85 (29) 69 (41) 75 (70) 0.06
Aminoglycosides 65 (22) 27 (16) 42 (39) <0.01
Co-amoxiclav 94 (32) 19 (11) 46 (43) <0.001
Cefoxitin 41 (13) 11 (7) 22 (20) <0.001
Nitrofurantoin 0 0 0 NS
Fosfomycin 0 0 0 NS

*ESBL, extended-spectrum β-lactamase; NS, not significant.

Main Article

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external